Related by context. All words. (Click for frequent words.) 60 FEV1 55 forced expiratory volume 50 trough FEV1 49 log# 49 Forced expiratory volume 49 QTcF 48 P = .# 48 LVEF 48 mg kg 48 GFR 48 FEV1 forced expiratory 48 glycated hemoglobin HbA1c 48 virologic response 47 ml kg 47 log# copies mL 47 ADAS cog 47 μmol L 47 mL 47 HAQ DI 46 -#.# mg dL [002] 46 HOMA IR 46 D dimer 46 HCV RNA 46 creatinine clearance 46 g dL 46 pulmonary exacerbations 46 CI -#.# 46 Unified Parkinson Disease 46 ng mL 46 mcg 46 IPSS 46 MADRS score 45 glomerular filtration rate 45 hemoglobin concentration 45 alanine aminotransferase ALT 45 serum sodium 45 #mg/day [001] 45 fasting plasma glucose FPG 45 apnea hypopnea index 45 HbA1c levels 45 mL kg 45 mL/min/#.# m 2 45 FEV ^ sub 45 MANN + HUMMEL 45 NIHSS score 45 mcg mL 45 albumin creatinine ratio 45 serum HBV DNA 45 baseline HbA1c 45 PSA nadir 45 leukocyte count 45 eGFR 44 PaO 2 44 mmHg 44 mg kg dose 44 Cmax 44 baseline FEV 44 nmol L 44 ng dL 44 albumin excretion 44 mg dL 44 plasma concentrations 44 Buehler Motor 44 tiotropium 44 serum concentrations 44 tipranavir r 44 serum urate 44 p = #.# [002] 44 Hb A1C 44 Capacity FVC 44 lumbar spine BMD 44 -#.# log# 44 mL/min/#.# m2 44 g dl 44 oral glucose tolerance 44 CD4 + cell 44 plasma leptin 44 virologic failure 44 MMSE score 44 ug kg 44 μg 44 HIV RNA 44 μg kg 44 clinically meaningful improvement 44 Index CDAI 44 hsCRP levels 44 ABC/3TC 43 copies mL 43 Forced Vital 43 serum IGF 43 recurrent VTE 43 certolizumab 43 mg QD 43 mcg kg 43 lopinavir r 43 pulmonary function 43 serum creatinine 43 overt nephropathy 43 serum potassium 43 ATACAND 43 fosamprenavir 43 mg BID 43 DLCO 43 LPV r 43 inotropic 43 fasting insulin 43 Serum creatinine 43 systolic 43 MetS 43 pg ml 43 peginterferon alfa 2b 43 statistically significant p = 43 per deciliter mg 43 Kolbenschmidt Pierburg 43 Crohn Disease Activity 43 lopinavir r arm 43 forced expiratory 43 oxycodone CR 43 eplerenone 43 albumin excretion rate 43 aspartate aminotransferase AST 43 pulmonary exacerbation 43 NIH CPSI 43 BYSTOLIC 43 TDF FTC 43 OGTT 43 CK MB 43 lung function 43 macroalbuminuria 43 placebo p 43 sUA 42 FFNS 42 μg liter 42 LEXIVA r 42 mmol L 42 systolic blood pressure 42 dapagliflozin plus 42 virological response 42 ng dl 42 urinary sodium excretion 42 Psoriasis Area 42 urine albumin 42 p = #.# [004] 42 Forced Expiratory Volume 42 IU mL 42 creatinine ratio 42 nmol liter 42 NATRECOR R 42 timepoint 42 mIU L 42 UPDRS 42 Scale cognitive subscale 42 Scuderi Split Cycle 42 alanine aminotransferase 42 #mg QD [002] 42 mm Hg systolic 42 BENICAR HCT 42 definite stent thrombosis 42 symptomatic VTE 42 mEq L 42 hemoglobin A1c HbA1c 42 p = 42 p = .# [002] 42 ALVESCO 42 ng ml 42 pulmonary capillary wedge 42 placebo 42 bronchodilation 42 nmol 42 NYHA functional class 42 clinically meaningful improvements 42 serum creatinine levels 42 Score IPSS 42 ≥ 42 #mg/kg [002] 42 n = 42 intramuscular dose 42 plasma HCV RNA 42 Alzheimer Disease Assessment 42 hemoglobin concentrations 42 concomitant medications 42 pg mL 42 HDRS 42 mm Hg 42 neutrophil counts 42 salmeterol fluticasone propionate 42 mg kg hr 42 corticosteroid dose 42 beta2 agonist 42 HBeAg seroconversion 42 aminotransferase elevations greater 42 CNS LS 42 mcg Albuferon 42 μg ml 42 creatinine levels 41 #mg/dL [002] 41 mcg BID 41 estimated GFR 41 vasopressor 41 apo B apo AI 41 serum phosphorus 41 intraventricular 41 NYHA 41 serum phosphate levels 41 aminotransferases 41 dyspnea 41 adenotonsillectomy 41 mL min 41 glycated hemoglobin levels 41 microg 41 Secondary endpoints 41 A1C levels 41 #.#/#.# mmHg [001] 41 glycosylated hemoglobin HbA1c 41 systolic dysfunction 41 4mg/kg 41 ml min 41 specific antigen PSA 41 Ejection Fraction 41 mL sec 41 HbA 1c 41 PSADT 41 abacavir lamivudine 41 nanomoles per 41 serum urate levels 41 Lupuzor ™ 41 peginterferon alfa 2a #KD 41 International Prostate Symptom 41 -#.# ± [002] 41 mcg dose 41 ventilatory 41 hour bronchodilation 41 mmol l 41 mg dose 41 triiodothyronine 41 mg ustekinumab 41 binary restenosis 41 Elitek 41 intramuscularly 41 NIHSS 41 hematological parameters 41 placebo p = 41 antibody titer 41 EDSS score 41 tirofiban 41 diastolic blood pressure 41 plasma glucose 41 ejection fraction 41 PCWP 41 aspartate aminotransferase 41 mg qd 41 HbA 1c levels 41 #.#/#.# mm Hg [003] 41 serum testosterone 41 biochemical relapse 41 peak VO2 41 LV ejection fraction 41 highest tertile 41 microalbuminuria 41 moderate renal impairment 41 ± 41 plasma uric acid 41 posttransplant 41 serum phosphorous 41 osmolality 41 serum PSA 40 ug mL 40 lispro 40 μg dose 40 adiponectin concentrations 40 PASI scores 40 PREZISTA ritonavir 40 isoprostane 40 Peg IFN 40 plus ribavirin 40 HBeAg negative patients 40 HI titers 40 mmHg systolic 40 statistically significant p 40 serum uric acid 40 corrected QT interval 40 H2RAs 40 transaminase elevations 40 μg mL 40 Kaplan Meier analysis 40 methotrexate monotherapy 40 SCr 40 adjunctive placebo 40 extrapyramidal symptoms 40 mg d 40 insulin detemir 40 Hb 40 subclinical hypothyroidism 40 dosing cohort 40 postoperatively 40 mmHg diastolic 40 pulmonary arterial 40 anemia hemoglobin 40 achieved ACR# 40 #mg dose [001] 40 urinary excretion 40 activated partial thromboplastin 40 IELT 40 infarct size 40 SGPT 40 IGFBP 40 baseline A1C 40 morphometric vertebral fractures 40 mU liter 40 AUC0 40 #μg [001] 40 aftertreatment 40 LANTUS R 40 mIU mL 40 #mg BID [003] 40 bronchopulmonary dysplasia 40 hours postdose 40 mmol 40 Secondary efficacy endpoints 40 nadolol 40 adefovir 40 exhaled NO 40 β blockers 40 NPH insulin 40 plasma folate 40 plus methotrexate 40 expiratory flow 40 Lantus ® 40 posttreatment 40 plasma cortisol 40 log# reduction 40 annualized relapse 40 follicle stimulating hormone FSH 40 GnRH agonist 40 methacholine 40 spirometric 40 serum phosphate 40 -#.# mmHg 40 airflow obstruction 40 preserved ejection fraction 40 mcg doses 40 peginterferon alfa 2a 40 ACTEMRA TM 40 Non inferiority 40 CCyR 40 #mg/day [002] 40 anagrelide 40 CCR5 tropic HIV 40 5-FU/LV 40 SGRQ 40 elevated serum creatinine 40 μg L 40 fractional shortening 40 leukopenia 40 HBV DNA levels 39 cilostazol 39 RadMax ® 39 mcg QD 39 administered subcutaneously 39 hyperphenylalaninemia HPA due 39 p = NS 39 mechanical ventilation 39 serum HCV RNA 39 intravenous diuretics 39 ACR Pedi 39 MACCE 39 β blocker 39 mcg dL 39 laboratory abnormalities 39 bosentan 39 timepoints 39 mean baseline A1C 39 neutrophil count 39 Nesiritide 39 tertiles 39 calculated creatinine clearance 39 gastric pH 39 complete cytogenetic response 39 secondary efficacy endpoint 39 FiO 39 serum aminotransferase levels 39 ‰ ¥ 39 CD4 CD8 39 serum estradiol 39 deciliter 39 q#h 39 methacholine challenge 39 QTc interval 39 Secondary endpoints include 39 expiratory volume 39 % CI #.#-#.# [006] 39 biochemical recurrence 39 liver histology 39 unfractionated heparin 39 iPTH 39 -#.# log# copies mL 39 nonsignificant 39 oxygen desaturation 39 p = .# [001] 39 postoperative mortality 39 urinary albumin 39 intima media thickness 39 LAB GHRH 39 mcg kg min 39 pulmonary vascular 39 PRADAXA #mg 39 IFN alfa 39 AGILECT R 39 3mg/kg 39 serum prostate 39 8mg/kg 39 CTEPH 39 angiotensin converting enzyme ACE 39 SpO 2 39 Qmax 39 Platelet counts 39 dobutamine 39 EUFLEXXA R 39 rosuvastatin #mg 39 serum CRP 39 baseline CD4 39 mcg albinterferon alfa 2b 39 SUVmax 39 6MWT 39 HBeAg positive 39 #mg BID [001] 39 postintervention 39 symptom exacerbation 39 confidence interval CI 39 Endothelial function 39 dalteparin 39 UACR 39 dose cohort 39 mg dl 39 inspiratory 39 intravenous bolus 39 evaluable subjects 39 postdose 39 peak expiratory flow 39 μg dL 39 cytogenetic response 39 serum albumin 39 death reinfarction 39 HbA1C levels 39 serum magnesium 39 urinary N telopeptide 39 serum sodium levels 38 BMW ActiveE 38 steroid dexamethasone 38 expiratory 38 fasting plasma glucose 38 hyperoxia 38 Thal Dex 38 flow mediated dilation 38 NYHA Class III 38 mg kg bw 38 airway responsiveness 38 CrCl 38 ropivacaine 38 Apgar scores 38 glomerular filtration 38 hypertonic saline 38 ACE inhibitor ramipril 38 ejection fraction EF 38 mcg ml 38 detrusor 38 tolvaptan 38 hypertensives 38 periprocedural 38 ^ sup 38 neonatal morbidity 38 mg/# hours 38 aldosterone antagonists 38 uL 38 ascending dose 38 adriamycin 38 titrated 38 Auto Show NAIAS 38 #.#mmol L [002] 38 % Confidence Interval 38 depressive symptomatology 38 lactate dehydrogenase 38 exhaled nitric oxide 38 6MWD 38 reach statistical significance 38 aminotransferase ALT 38 colorectal adenoma 38 REYATAZ r arm 38 #ng/ml 38 echocardiographic parameters 38 retinal thickness 38 intact parathyroid hormone 38 EDARBI 38 pmol L 38 mediated dilation 38 mU 38 irbesartan 38 hypokalemia 38 NYHA class 38 fasting serum 38 mg TID 38 spirometry 38 euthyroid 38 oxcarbazepine 38 micromoles 38 #OHD 38 Rating Scale MADRS 38 inhaled nitric oxide 38 test OGTT 38 BLLs 38 peak plasma concentrations 38 piperacillin tazobactam 38 chlorambucil 38 confidence interval #.#-#.# 38 NNRTI resistance 38 Visual Analogue Scale VAS 38 microgram kg 38 epoetin alfa 38 systolic BP 38 left ventricular systolic 38 MBq 38 bolus injection 38 TIMP 38 Montgomery Asberg Depression 38 glucuronide 38 interquartile range 38 #ug [001] 38 Mechanical ventilation 38 mg/m2 38 #mm Hg 38 statistical significance p 38 left ventricular dysfunction 38 #mg/m# [001] 38 dehydroepiandrosterone sulfate 38 thyrotropin 38 GETRAG 38 CI #.#-#.# [001] 38 serum cortisol 38 indinavir 38 paricalcitol 38 serum TSH 38 PROLASTIN 38 % CI #.#-#.# [003] 38 azacytidine 38 μg dl 38 hemoglobin Hb 38 rFSH 38 tinzaparin 38 Montgomery Åsberg Depression 38 HbA1C 38 CR nPR 38 tertile 38 urinary cortisol 38 HAM D# scores 38 graft dysfunction 38 gestational hypertension 38 uM 38 mean corpuscular volume 38 BorgWarner 38 apolipoprotein B 38 amprenavir 38 #mg/m# [002] 38 MaxxForce engines 38 mg orally 38 ertapenem 38 glulisine 38 solifenacin 38 triglyceride concentrations 38 PREZISTA r arm 38 bypass graft CABG surgery 38 hydroxyvitamin D levels 38 logistic regression model 37 multivariable analysis 37 neurodevelopmental outcome 37 candesartan 37 Viral load 37 Index CDAI score 37 diastolic blood pressures 37 q8h 37 multivariate adjustment 37 ProStar ® 37 % CI #.#-#.# [007] 37 protein excretion 37 pressor response 37 bronchial reactivity 37 beta blocker therapy 37 IIIa inhibitors 37 COPD 37 bronchial hyperresponsiveness 37 serum sodium concentration 37 microliters 37 IOP lowering 37 baseline serum creatinine 37 ketorolac 37 CDAI score 37 XIENCE V demonstrated 37 ìg 37 nondiabetic patients 37 oral antidiabetic medication 37 exhaust aftertreatment 37 nmol L. 37 #.#ng/ml 37 plasma glucose levels 37 plasma urate 37 fluticasone salmeterol 37 prospectively stratified 37 dosing cohorts 37 Secondary endpoints included 37 pneumonectomy 37 thromboembolic 37 severe neutropenia 37 hypoxemia 37 fasting triglyceride levels 37 ADCS ADL 37 cTnT 37 Tumor shrinkage 37 iloprost 37 reintubation 37 COZAAR 37 CVD mortality 37 rizatriptan 37 TNF alpha IL 37 BluePerformance 37 % CI #.#-#.# [001] 37 mg tid 37 atherogenic dyslipidemia 37 WOMAC pain 37 Negative Syndrome 37 #mg dose [002] 37 hemodynamic variables 37 experienced virologic failure 37 divalproex sodium 37 moderate hepatic impairment 37 RNA copies mL 37 #.#mg/kg [002] 37 NSTE ACS 37 fraction LVEF 37 renal dysfunction 37 MCyR 37 glycosylated hemoglobin levels 37 virologic breakthrough 37 mg 37 MAHLE Powertrain 37 baseline FEV1 37 postprandial insulin 37 glycated hemoglobin 37 baseline Hb 37 micromolar 37 plasminogen activator inhibitor 37 detrusor overactivity 37 NYHA Class II 37 troponin T 37 mg/# h 37 coronary calcification 37 aged ≥ 37 hemoglobin A1c levels 37 CSBMs 37 NATRECOR ® 37 recurrent wheezing 37 nonfasting triglyceride levels 37 μg d 37 lipoprotein Lp 37 urinary oxalate 37 cortisol concentrations 37 thyrotropin levels 37 acute decompensation 37 nausea photophobia 37 urinary iodine 37 #mmHg [001] 37 nasal symptom 37 STN stimulation 37 cardiovascular hospitalizations 37 tHcy concentrations 37 kPa 37 lowest tertile 37 prospectively defined 37 elevated LDH 37 nonfatal MI 37 pmol liter 37 bolus dose 37 mm Hg diastolic 37 hypovolemic 37 injectable emulsion 37 Lantus R 37 â ‰ ¥ 37 CDAI 37 atheroma volume 37 QTc prolongation 37 autonomic dysfunction 37 Lotus Engineering 37 DEUTZ 37 neurologic progression 37 nadroparin 37 ALT normalization 37 IBDQ 36 CANCIDAS 36 APTIVUS r 36 Tiotropium 36 intravesical 36 μl 36 nighttime awakenings 36 Caterpillar C# 36 Score DAS# 36 kg -1 36 undetectable HBV DNA 36 endometrial thickness 36 alteplase 36 Ozarelix 36 symptom severity 36 PANSS total 36 bronchoalveolar lavage 36 Q2W 36 KRAS mutations occur 36 oral allopurinol 36 amoxicillin clavulanate 36 intraocular pressure IOP 36 serum calcium 36 diuretic chlorthalidone 36 normal ULN 36 systolic ejection 36 QD dosing 36 nmol l 36 sodium excretion 36 mg RDEA# 36 aminotransferase levels 36 FEV1 Forced Expiratory Volume 36 urate lowering therapy 36 alanine transaminase 36 bacteriuria 36 RfD 36 daunorubicin 36 micrograms mcg 36 saline placebo 36 GERD symptom 36 #mL [002] 36 pyrazinamide 36 variceal hemorrhage 36 arterial oxygen saturation 36 plasma renin 36 clodronate 36 vasodilatation 36 #.#mmHg 36 Systolic 36 gadolinium enhancing lesions 36 lanthanum carbonate 36 metabolic parameters 36 mm ³ 36 asthma exacerbation 36 kg m² 36 budesonide pMDI 36 EDSS scores 36 nM 36 CK # plasma 36 atorvastatin #mg 36 intra articular injection 36 salmeterol fluticasone 36 rFVIIa 36 Intrathecal 36 min -1 36 adefovir treated 36 ECOTEC 36 hemodilution 36 Apidra ® 36 highly emetogenic 36 ALS Functional 36 blood oxygen saturation 36 racemic albuterol 36 Serious Adverse Events 36 gliclazide 36 lymphocytosis 36 candesartan cilexetil 36 isolated systolic hypertension 36 kilogram mg kg 36 #μg [002] 36 ElectroJet 36 mol L 36 pyridostigmine 36 pretreatment baseline 36 clinically meaningful reductions 36 Myelosuppression 36 atazanavir ritonavir 36 sievert 36 cardiogenic shock 36 SRBD 36 QTc intervals 36 comparator arm 36 cerebrovascular accident 36 myocardial viability 36 systolic diastolic blood 36 blood glucose concentrations 36 aldosterone antagonist 36 OTCBB FDMLQ 36 #.#mg/dL 36 inhaled budesonide 36 metabolite concentrations 36 cerebrovascular events 36 Hybrid Vehicle 36 mCi kg 36 estimated glomerular filtration 36 Scale EDSS score 36 Prehypertension 36 per milliliter 36 pentoxifylline 36 ejection fractions 36 mg/m2 dose 36 Ed Welburn vice 36 serum leptin 36 cytopenias 36 plasma glucose concentrations 36 recurrent ischemia 36 p ≤ 36 preintervention 36 epistaxis 36 systemic hypotension 36 ventricular ejection fraction 36 apnea hypopnea 36 oral prednisone 36 ipsilateral stroke 36 HCV replicon 36 mg m 36 RBC folate 36 Aftertreatment 36 triglycerides HDL 36 detectable HCV RNA 36 normothermic 36 -#.# ± [001] 36 Plasma concentrations 36 Hemoglobin A1c HbA1c 36 abdominal circumference 36 severe renal impairment 36 overt hypothyroidism 35 tHcy 35 maximal treadmill 35 ceftazidime 35 artery stenosis 35 hepatorenal syndrome 35 fasting glucose levels 35 rhEPO 35 IV bolus 35 Morse TEC 35 microliter 35 Acetate Rectal Suppositories 35 fluid overload 35 #.#mg/kg [001] 35 systolic blood pressures 35 Dyspnea 35 mU L 35 bronchoalveolar lavage fluid 35 CHD mortality 35 Kogenate FS 35 serum thyroglobulin 35 cardiovascular mortality 35 Hazard Ratio HR 35 myocardial reperfusion 35 anti HBs 35 interleukin IL -6 35 urate levels 35 bronchoalveolar lavage BAL 35 mm3 35 walk distance 6MWD 35 systolic function 35 TEAEs 35 plasma selenium 35 natriuresis 35 hypopneas 35 nasal lavage 35 nonfatal myocardial infarction 35 Bosch Rexroth 35 d amphetamine 35 lopinavir ritonavir 35 mIU ml 35 covariate 35 8 OHdG 35 HRQL 35 budesonide formoterol 35 Left Ventricular Ejection Fraction 35 dopamine partial agonist 35 unresectable HCC 35 multivariable adjusted 35 pCR 35 angiotensin converting enzyme 35 subcutaneously administered 35 mild renal insufficiency 35 P ≤ 35 chemoradiation therapy 35 intravascular volume 35 #mmHg [002] 35 hypogonadal men 35 SAE 35 extubation 35 alpha blocker 35 3mg 35 Expanded Disability Status 35 TURBT 35 severe oral mucositis 35 postoperative complication 35 cfu 35 plasma fibrinogen 35 hMG 35 decompensation Child Pugh 35 reflux symptoms 35 #mL [001] 35 Automotive Engineers SAE 35 arterial stiffness 35 diastolic BP 35 LV dysfunction 35 EGR engines 35 ventricular remodeling 35 serum IgE 35 aldosterone 35 #degreesC 35 picoCuries 35 octreotide LAR 35 neurodevelopmental outcomes 35 follicular phase 35 serum homocysteine 35 F FDG 35 HIV HCV coinfected 35 #.#-#.# [011] 35 mg/m2/day 35 ascending doses 35 OADs 35 Ishak fibrosis score 35 torr 35 asthma exacerbations 35 fluticasone propionate 35 fibrinolysis 35 systolic diastolic 35 reinfarction 35 mM 35 ARB telmisartan 35 coronary revascularization 35 1mg 35 rimonabant #mg 35 Folfox 35 del 5q MDS 35 MIC# [001] 35 adenosine diphosphate ADP 35 laxation 35 statin monotherapy 35 NaCl 35 APACHE II 35 oral prednisolone 35 Detonation Cycle Gas Turbine 35 ug ml 35 severe exacerbations 35 remifentanil 35 Fluticasone 35 daily subcutaneous injections 35 8mg 35 incontinence episodes 35 micrograms mL 35 IU ml 35 Wistar rats 35 Automotive Engineers 35 diastolic dysfunction 35 benazepril 35 #mg doses [002] 34 mg mL 34 pleural fluid 34 plasma triglycerides 34 deoxy 34 hemodynamic parameters 34 Atypical Hemolytic Uremic Syndrome 34 Ecoboost engine 34 mu g 34 hip BMD 34 mg subcutaneously 34 milliliters mL 34 serum calcium levels 34 SBM frequency 34 IQR 34 DULERA 34 postprandial glycemia 34 blood lactate 34 milliliter ng ml 34 fluticasone propionate FP 34 Retreatment 34 EyesOn Design 34 sitosterol 34 USCAR 34 systemic corticosteroids 34 oligohydramnios 34 perioperative mortality 34 cerebral perfusion 34 COPD exacerbation 34 g mL 34 M1 Hommage 34 epoetin alpha 34 pCi 34 CLA supplementation 34 RLS symptoms 34 Diastolic blood pressure 34 p = #.# [003] 34 tolterodine ER 34 mg Androxal 34 Saturn ION 34 NovoLog ® Mix 34 folic acid supplement